Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Androgen Receptor Polymorphism on Endometrial Cancer Development, Progression, and Outcome

NCT05157373 is registered in ClinicalTrials.gov with University of Nicosia as lead sponsor.

NCT NCT05157373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05157373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Androgen Receptor Polymorphism on Endometrial Cancer Development, Progression, and Outcome
Lead sponsor
University of Nicosia
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2022
Completion date
April 1, 2024
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

androgen receptor abnormal, endometrial disorder